AbCellera Biologics Inc.
ABCL
|
|
| |
|
| Trading Volume | 51,754 |
|
|
5.97 - 2.50 |
| Market Cap Full | $ 757.3M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 6.3% | -20.7% | -25.6% | -31.8% |
| Q2 | - | -14.1% | -14.3% | 9.2% |
| Q3 | - | -21.4% | -28.8% | -7.1% |
| Q4 | - | -0.5% | 28% | 2.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -10.5 | -1.2 | -10.3 | -15.7 | - | - | - | -21.4 | - | - | - | - |
| 2023 | |||||||||||
| 4 | -20.2 | -10.2 | -10.1 | 2.8 | -7.3 | 19.7 | -29.5 | -15.6 | -10.7 | 14.6 | 21.2 |
| 2022 | |||||||||||
| -37.1 | -4.8 | 13.9 | -21.3 | -0.7 | 39.8 | -5.7 | 6.4 | -7.4 | 19.6 | 8.8 | -21.3 |
| 2021 | |||||||||||
| 34.9 | -28.3 | -10.3 | -17.8 | -3.9 | -18 | -30.4 | 9.6 | 18.3 | -20.9 | -4.8 | -4.4 |
| 2020 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.1 | 0.5 | 0.4 | 0 |
| Q2 | -0.1 | -0 | -0 | 0 |
| Q3 | -0.1 | 0.1 | -0.1 | 0 |
| Q4 | 0 | -0.1 | 0.2 | 0 |
| A | -0.35 | 0.5 | 0.5 | 0.5 |